Our Team

Sara Cherry

Professor of Pathology of Laboratory Medicine, Microbiology and Biochemistry and Molecular Biophysics

Scientific Director, High-throughput Screening Core

Director, Program for Chemogenomic Discovery, PENN Center for Precision Medicine

Trevor Griesman

CAMB Graduate Student

Studies neuronal innate immunity to bunyaviruses

Jorge Acuña

CAMB Graduate Student

Studies SARS-CoV-2 entry mechanisms

Rachel Braun

BMB Graduate Student

Studies the role of the mRNA decay pathway in viral infection

Kaeri Martinez

CAMB Graduate Student

Studies diverse bunyaviruses and their interactions with hosts

Mark Dittmar

CAMB Graduate Student

Studies henipaviruses and antivirals against them

Tamanna Srivastava

BMB Graduate Student

Studies the role of innate immunity in viral infection

Steven Miller, PHD

Studies mechanisms by which the microbiota and innate immunity impact enteric infection in Drosophila

Jaeseung Lee, PhD

Focuses on the role of autophagy in SARS-CoV-2 and developing anti-viral drugs

Max Ferretti, PhD

(Joint with Dr. Kristen Lynch)

Uses transcriptomics, bioinformatics, and molecular biology to understand how RNA viruses manipulate hosts to promote infection

Guangda Shi, PhD

Studies nucleoside metabolic changes in response to SARS-CoV-2 infection and novel antiviral strategies

Priyanka Bhakt, PhD

Studies flaviviruses and antivirals against them.

Smita Bhutda

Studies role of NF-kB signaling pathway in SARS-CoV2 infection for developing novel therapeutic drug targets.

Beth Gordesky Gold, PhD

Explores virus-host interactions in Drosophila

Jesse Hulahan

Studies antivirals against emerging viruses

Swechha Mainali Pokharel

Studies antivirals against emerging viruses

Yue Li

Studies antivirals against emerging viruses

Glenn Hogan

Studies cell-mediated immunity against influenza and SARS-CoV-2

Benjamin Gabriel, PhD

Studies innate immune responses against SARS-CoV-2Studies innate immune responses against SARS-CoV-2

Ashley Abraham

Oleksandr Zginnyk